SUMMARY Intravenous lignocaine (1-5 mg kg-') was evaluated in patients undergoing intraocular surgery as a means of preventing the rise in intraocular pressure which accompanies tracheal intubation. In patients given either suxamethonium or pancuronium to facilitate tracheal intubation, lignocaine pretreatment conferred no benefit over placebo in preventing the intraocular hypertensive response.
Laryngoscopy and tracheal intubation induce potent cardiovascular pressor responses which may cause myocardial ischaemia and cardiac arrhythmias in susceptible patients.' They also cause a significant increase in intracranial2 and intraocular pressures,3 which may have serious consequences in certain patients.
Intravenous lignocaine has been used with some success in attenuating these responses. Hamill et al.4 found that intravenous lignocaine (1.5 mg kg-') reduced but did not completely abolish the haemodynamic effects of laryngoscopy and intubation. Donegan and Bedford2 found that intracranial pressure (ICP) fell following intravenous lignocaine and that the rise in ICP accompanying tracheal suctioning was also attenuated. Poulton and James5 found that intravenous lignocaine in a dosage of 1-5 mg kg-' could significantly suppress the cough reflex.
Little work has been done in assessing intravenous lignocaine for prevention ofintraocular hypertension. A recent review of the effects of anaesthesia on intraocular pressure6 showed that no presently used method of preventing suxamethonium-induced intraocular hypertension was completely effective. In view of the success of intravenous lignocaine in attenuating the haemodynamic responses and ICP rise accompanying tracheal intubation it seemed worthwhile to assess its efficacy in preventing the rise in intraocular pressure which also accompanies this manoeuvre. The aim of the present study was to evaluate the effect of lignocaine pretreatment on suxamethonium induced intraocular hypertension and its effect on intraocular pressure changes following tracheal intubation.
Patients and methods
Adult patients giving informed consent and undergoing cataract surgery under general anaesthesia were included prospectively into the study. Premedication was with oral diazepam 10 mg, given 90 minutes prior to surgery.
The patients were grouped by random number sequence into those who received suxamethonium (1.5 mg kg-') and those who received pancuronium (0-1 mg kg-') for muscle relaxation and subgrouped into those who received intravenous lignocaine (1.5 mg kg-') pretreatment and those who received placebo.
The anaesthesia sequence for patients given suxamethonium involved administration of lignocaine or placebo followed one minute later by thiopentone (4-5 mg kg-') and then suxamethonium (1-5 mg kg-') one minute after completion ofthiopentone injection. Tracheal intubation was performed one minute after suxamethonium injection. In these patients intraocular pressure was measured just before suxamethonium administration, just before laryngoscopy, and one minute after tracheal intubation.
The anaesthesia sequence for patients given pancuronium involved administration of lignocaine or placebo followed one minute later by thiopentone 596 
Results
A total of 40 patients were studied, 10 in each subgroup. No significant differences between the subgroups were seen with regard to age, sex, and weight (Table 1 ).
In the suxamethonium subgroups the change in IOP (mean 0-35 mmHg±2*68 SD), following suxamethonium administration failed to reach statistical significance. However, in these subgroups the IOP was significantly increased (mean 4 05 mmHg±3*145 SD, p<0-001) following tracheal intubation (Table  2 ).
In the pancuronium subgroups a similar significant increase in IOP followed tracheal intubation (mean 5.4 mmHg±4*67 SD, p<0.001). The systemic arterial pressure and heart rate increased in parallel with the IOP in all cases (Table 3) .
In both the suxamethonium subgroups and the Many drugs have been used in an attempt to obtund the undesirable effects of suxamethonium and tracheal intubation, including small doses of nondepolarising neuromuscular blocking drugs,7" 'selftaming' with small doses of suxamethonium8 and with preinduction doses of intravenous diazepam,' hexafluorenium, " and acetazolamide." No method of pretreatment has been found to be completely satisfactory.6 A review of the literature showed that, though intravenous lignocaine pretreatment has been the subject of a number of studies, only one evaluated its effect on intraocular pressure. Smith 
